On this page:Overview Publications Researchers Institutions Open access

PICO Portalanswers from OpenAlex

Kishiwada City Hospital

InstitutionResearch output, impact & collaborations

Kishiwada City Hospital is a institution indexed in PICO Portal from OpenAlex.

What is known about Kishiwada City Hospital?

PICO Portalrecord summary

Kishiwada City Hospital is a research organisation in Osaka, JP. OpenAlex records 1,033 works and 33,341 citations for it. 273 researchers list it as their most recent affiliation.

How many works does Kishiwada City Hospital have?

PICO Portalindexed works

Kishiwada City Hospital has 1,033 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Kishiwada City Hospital →

How many citations does Kishiwada City Hospital have?

PICO Portalcitation count

Kishiwada City Hospital has 33,341 citations in the OpenAlex counts PICO Portal stores.

See the listed works for Kishiwada City Hospital →

How many researchers are at Kishiwada City Hospital?

PICO Portalresearcher count

Kishiwada City Hospital has 273 researchers in the PICO Portal index.

See the researchers listed on this page →

What is the average h-index at Kishiwada City Hospital?

PICO Portalavg h-index

Kishiwada City Hospital has an average h-index of 13.5 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Kishiwada City Hospital?

PICO Portalror

The ROR for Kishiwada City Hospital is on the source record.

Open the ROR →

What is the OpenAlex record for Kishiwada City Hospital?

PICO Portalopenalex

The OpenAlex for Kishiwada City Hospital is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Kishiwada City Hospital?

PICO Portaltop researchers by citations

Satomi Watanabe · HER2/EGFR in Cancer Research

133 works888 citations

Soichi Fumita · Gastrointestinal motility and disorders

41 works832 citations

What are the most-cited papers on Kishiwada City Hospital?

PICO Portalmost cited works

Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)

Narikazu Boku, Min‐Hee Ryu, Ken Kato, Hyun Cheol Chung, Keiko Minashi, K.-W. Lee, H. Cho, Won Ki Kang, Yoshito Komatsu, Masahiro Tsuda, Kensei Yamaguchi, Hiroki Hara, Soichi Fumita, Mizutomo Azuma, L.-T. Chen, Yoon‐Koo Kang

Annals of Oncology. 2018325 CitationsOPEN ACCESS

An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC

Kimio Yonesaka, Naoki Takegawa, Satomi Watanabe, Koji Haratani, Hisato Kawakami, Kazuko Sakai, Yasutaka Chiba, Naoyuki Maeda, Takashi Kagari, Kenji Hirotani, Kazuto Nishio, Kazuhiko Nakagawa

Oncogene. 2018102 Citations

Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors

Masayuki Takeda, Takayuki Takahama, Kazuko Sakai, Shigeki Shimizu, Satomi Watanabe, Hisato Kawakami, Kaoru Tanaka, Chihiro Sato, Hidetoshi Hayashi, Yoshikane Nonagase, Kimio Yonesaka, Naoki Takegawa, Tatsuya Okuno, Takeshi Yoshida, Soichi Fumita, Shinichiro Suzuki, Koji Haratani, Kazumasa Saigoh, Akihiko Ito, Tetsuya Mitsudomi, Hisashi Handa, Kazuya Fukuoka, Kazuhiko Nakagawa, Kazuto Nishio

The Oncologist. 202097 CitationsOPEN ACCESS

Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer

Satomi Watanabe, Kimio Yonesaka, Junko Tanizaki, Yoshikane Nonagase, Naoki Takegawa, Koji Haratani, Hisato Kawakami, Hidetoshi Hayashi, Masayuki Takeda, Junji Tsurutani, Kazuhiko Nakagawa

Cancer Medicine. 201975 CitationsOPEN ACCESS

HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer

Naoki Takegawa, Kimio Yonesaka, Kazuko Sakai, Hiroto Ueda, Satomi Watanabe, Yoshikane Nonagase, Tatsuya Okuno, Masayuki Takeda, Osamu Maenishi, Junji Tsurutani, Taroh Satoh, Isamu Okamoto, Kazuto Nishio, Takao Tamura, Kazuhiko Nakagawa

Oncotarget. 201570 CitationsOPEN ACCESS

How much of the research on Kishiwada City Hospital is open access?

PICO Portalopen access share

58%OPEN ACCESS

Gold

33%

Green

Hybrid

Bronze

17%

Closed

42%